2016 October 09

The New PB Shirts Are Here!

Help support Plunderbund and get some cool American made, union printed gear!

Help Plunderbund!

Plunderbund Sues Over Charter Scandal Records

After months of delays, Plunderbund has sued Kasich’s education department of public records

Voters Need A Voice On School Board

ECOT Lies About Enrollment Numbers

Ohio’s Largest Online Charter School, ECOT, Has Disturbingly Overstated Student Enrollment

Ohio Alliance For Public Charter Schools Going Out Of Business

The dismal reputation of Ohio’s charter industry may be the reason funders have withdrawn their support of OAPCS.

Help Fight Back Against Trump’s Agenda In Ohio

Here’s a quick list of some of the groups in Ohio that will be actively working against Trump’s backwards and divisive agenda.

From the daily archives: Sunday, October 9, 2016

No Tic Tac For Tacky Trump

On October 9, 2016 By Abe

Rob Portman, who is continuing to grope for a subliminal moment with the Trump crowd, is now saying that he will write in Mike Pence’s name on the November ballot. Yippee! That’s one way to save face for his long delayed disavowal of Donald Trump.

At least the theocratic Indiana governor said he could not put up with Trump’s adolescent sexual trash talk and promised to pray for him. And Rudy Giuliani, who sees a possible fat appointment to a Trump cabinet vanishing, is defending him now as an imperfect human being since Jesus is the only perfect one. Can […]

Full Story... →

Portman’s Push on EpiPen Pricing Probably Another “EmptyPromise”

On October 9, 2016 By Travis Irvine

Last month Ohio’s junior senator Rob Portman made headlines with astute political timing by joining Missouri Democrat Claire McCaskill to probe the rising price of EpiPens, an emergency treatment product that counteracts severe allergic reactions. Since its inception, the company that makes the epinephrine injections, Mylan Pharmaceuticals, has enthusiastically raised the price for a pack of two EpiPens from $100 back in 2009 to as much as $600 today, so their heads were clearly on a public chopping block.

Portman and McCaskill notified the media in September that they had “opened a preliminary inquiry concerning Mylan Pharmaceuticals’ pricing and competition practices with respect to the EpiPen,” […]